CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$1.08
+0.01 (+0.93%)
Open$1.08
Previous Close$1.07
Day High$1.11
Day Low$1.06
52W High$14.64
52W Low$1.00
Volume—
Avg Volume118.7K
Market Cap4.00M
P/E Ratio—
EPS$-4.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,469.4% upside
Current
$1.08
$1.08
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.07M | 2.13M | 1.91M |
| Net Income | 662.5K | 666.1K | 461.6K |
| Profit Margin | 32.0% | 31.3% | 24.1% |
| EBITDA | 955.8K | 1.01M | 1.06M |
| Free Cash Flow | 570.9K | 515.8K | 427.8K |
| Rev Growth | +2.5% | +18.2% | +2.4% |
| Debt/Equity | 0.18 | 0.20 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |